•
Jun 30, 2011

EyePoint Pharmaceuticals Q4 2011 Earnings Report

Total Revenue
$3.72M
Previous year: $23.1M
-83.9%
EPS
-$4.4
Previous year: $4.8
-191.7%
Gross Profit
$3.72M
Previous year: $15.7M
-76.4%
Cash and Equivalents
$12.9M
Previous year: $15.5M
-16.8%
Free Cash Flow
$1.18M
Previous year: $9.88M
-88.1%
Total Assets
$47.1M

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals